SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 348 filers reported holding SEATTLE GENETICS INC in Q1 2019. The put-call ratio across all filers is 1.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $40,620,000 | +340.8% | 239,058 | +199.3% | 0.07% | +51.1% |
Q1 2020 | $9,216,000 | -38.0% | 79,872 | -38.6% | 0.05% | -17.5% |
Q4 2019 | $14,854,000 | +122.2% | 130,001 | +66.1% | 0.06% | +83.9% |
Q3 2019 | $6,685,000 | +24.7% | 78,277 | +1.1% | 0.03% | +19.2% |
Q2 2019 | $5,361,000 | -33.7% | 77,463 | -29.8% | 0.03% | -35.0% |
Q1 2019 | $8,087,000 | +36.6% | 110,421 | +5.7% | 0.04% | +33.3% |
Q4 2018 | $5,922,000 | -29.4% | 104,514 | -3.9% | 0.03% | -26.8% |
Q3 2018 | $8,391,000 | -23.0% | 108,803 | -33.7% | 0.04% | -19.6% |
Q2 2018 | $10,895,000 | +54.0% | 164,106 | +21.4% | 0.05% | +45.7% |
Q1 2018 | $7,075,000 | +1.4% | 135,181 | +3.7% | 0.04% | +2.9% |
Q4 2017 | $6,974,000 | -29.4% | 130,363 | -28.2% | 0.03% | -32.0% |
Q3 2017 | $9,874,000 | -9.4% | 181,469 | -13.8% | 0.05% | -16.7% |
Q2 2017 | $10,894,000 | +14.5% | 210,550 | +39.1% | 0.06% | +42.9% |
Q1 2017 | $9,514,000 | +30.7% | 151,345 | +9.7% | 0.04% | +16.7% |
Q4 2016 | $7,281,000 | -12.5% | 137,967 | -10.4% | 0.04% | -7.7% |
Q3 2016 | $8,319,000 | +13.4% | 154,030 | -15.1% | 0.04% | +2.6% |
Q2 2016 | $7,335,000 | -5.4% | 181,517 | -17.9% | 0.04% | -26.9% |
Q1 2016 | $7,757,000 | -22.2% | 221,065 | -0.5% | 0.05% | -34.2% |
Q4 2015 | $9,974,000 | +48.4% | 222,246 | +27.5% | 0.08% | +51.9% |
Q3 2015 | $6,721,000 | -35.6% | 174,292 | -19.2% | 0.05% | -16.1% |
Q2 2015 | $10,443,000 | +81.1% | 215,755 | +32.3% | 0.06% | +87.9% |
Q1 2015 | $5,765,000 | +53.0% | 163,074 | +39.0% | 0.03% | +43.5% |
Q4 2014 | $3,769,000 | -7.7% | 117,290 | +6.8% | 0.02% | +4.5% |
Q3 2014 | $4,082,000 | -4.2% | 109,796 | -1.5% | 0.02% | +10.0% |
Q2 2014 | $4,263,000 | -28.8% | 111,456 | -15.2% | 0.02% | -33.3% |
Q1 2014 | $5,987,000 | +34.0% | 131,407 | +17.4% | 0.03% | +30.4% |
Q4 2013 | $4,467,000 | -59.0% | 111,974 | -54.9% | 0.02% | -58.2% |
Q3 2013 | $10,890,000 | +46.4% | 248,464 | +5.1% | 0.06% | +34.1% |
Q2 2013 | $7,439,000 | – | 236,455 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |